11.51
+0.295(+2.63%)
Currency In USD
| Previous Close | 11.21 |
| Open | 11.45 |
| Day High | 11.75 |
| Day Low | 11.39 |
| 52-Week High | 14.91 |
| 52-Week Low | 3.91 |
| Volume | 274,436 |
| Average Volume | 1.16M |
| Market Cap | 793.01M |
| PE | -3.84 |
| EPS | -3 |
| Moving Average 50 Days | 12.83 |
| Moving Average 200 Days | 9.09 |
| Change | 0.3 |
If you invested $1000 in EyePoint Pharmaceuticals, Inc. (EYPT) 10 years ago, it would be worth $304.37 as of November 10, 2025 at a share price of $11.505. Whereas If you bought $1000 worth of EyePoint Pharmaceuticals, Inc. (EYPT) shares 5 years ago, it would be worth $2,614.77 as of November 10, 2025 at a share price of $11.505.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
EyePoint to Report Third Quarter 2025 Financial Results on November 5, 2025
GlobeNewswire Inc.
Oct 29, 2025 11:00 AM GMT
WATERTOWN, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today a
EyePoint Announces Pricing of Public Offering
GlobeNewswire Inc.
Oct 15, 2025 2:43 AM GMT
WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today a
EyePoint Announces Proposed Public Offering of Common Stock
GlobeNewswire Inc.
Oct 14, 2025 8:35 PM GMT
WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today a